Log in
Enquire now
Ally Bridge Group

Ally Bridge Group

Ally Bridge Group is a Hong Kong based investment group investing in the healthcare sector in Europe, the United States and China.

OverviewStructured DataIssuesContributors

Contents

ally-bridge.com
Is a
Investor
Investor
Company
Company
Organization
Organization
Venture capital firm
Venture capital firm

Company attributes

Industry
Cancer
Cancer
Biology
Biology
Biopharmaceutical
Biopharmaceutical
Investing
Investing
Technology
Technology
Biotechnology
Biotechnology
Location
New York City
New York City
Hong Kong
Hong Kong
B2X
B2C
B2C
Pitchbook URL
pitchbook.com/profiles.../60216-58
Full Address
Ally Bridge Group (NY) LLC 430 Park Avenue, 12th Floor New York, New York 10022
Ally Bridge Group (HK) Limited Gloucester Tower, The Landmark, 30th Floor 15 Queen’s Road Central, Hong Kong
Glassdoor ID
2576304

Venture Capital Firm attributes

Invested in
Goldfinch Bio
Goldfinch Bio
Syros Pharmaceuticals
Syros Pharmaceuticals
Shockwave Medical
Shockwave Medical
Quantum Surgical Sas
Quantum Surgical Sas
CARGO Therapeutics
CARGO Therapeutics
Wacai
Wacai
LinkDoc Technology
LinkDoc Technology
Arbor Biotechnologies
Arbor Biotechnologies
...

Other attributes

Company Operating Status
Active
Total Offering (USD)
100,000,000,000,000

Founded in 2011 by Frank Yu, Ally Bridge Group is a Hong Kong based investment group. They focus their investments in the healthcare sector in the United States, Europe and China. Their investments come at growth stage, late-stage, buyout or they will invest in hedge funds.

For their growth and late stage investments, Ally Bridge Group looks to invest in healthcare companies focused on pharmaceuticals and medical devices with near-term liquidity events or exits. For buyouts or large growth capital, they look to invest in cross-border healthcare companies or China-based healthcare companies with cross-border aspirations.

Investment

Ally Bridge Group has invested in WuXi AppTec, Grail, WuXi NextCode, Medtech, Shockwave Medical, NxThera, Quantum Surgical, Jinxin Fertility, Pulmonx, Duoning Biotech, GenFleet Therapeutics, Akeso Biopharma, Quantum Surgical, Innovent Biologics and Hua Medicine.

Ally Bridge Group has exited their investments in Sorrento Therapeutics, Synlogic, Shockwave Medical, TESARO, Innovent Biologics, Hua Medicine and Otonomy.

Timeline

No Timeline data yet.

Associated Investment Funds

Accelerator Batches

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Funding Rounds Participated In

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Ally Bridge Group

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.